Results
|
11121.
|
Etoposide versus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer. Results of a prospective randomized FONICAP trial. Italian Lung Cancer Task Force. [electronic resource] by
- Rosso, R
- Salvati, F
- Ardizzoni, A
- Gallo Curcio, C
- Rubagotti, A
- Belli, M
- Castagneto, B
- Fusco, V
- Sassi, M
- Ferrara, G
Producer: 19900726
In:
Cancer vol. 66
Availability: No items available.
|
|
11122.
|
|
|
11123.
|
High-dose intensification therapy with autologous bone marrow support for limited small-cell bronchogenic carcinoma. [electronic resource] by
- Spitzer, G
- Farha, P
- Valdivieso, M
- Dicke, K
- Zander, A
- Vellekoop, L
- Murphy, W K
- Dhingra, H M
- Umsawasdi, T
- Chiuten, D
Producer: 19860212
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 4
Availability: No items available.
|
|
11124.
|
|
|
11125.
|
|
|
11126.
|
[Effect of cranial irradiation on rate of recurrence in children with acute myeloid leukemia. Initial results of the AML-BFM-87 study. The AML-BFM Study Group]. [electronic resource] by
- Creutzig, U
- Ritter, J
- Heyen, P
- Berthold, F
- Henze, G
- Kabisch, H
- Lampert, F
- Niethammer, D
- Riehm, H
- Schellong, G
Producer: 19921008
In:
Klinische Padiatrie vol. 204
Availability: No items available.
|
|
11127.
|
|
|
11128.
|
|
|
11129.
|
|
|
11130.
|
|
|
11131.
|
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas. [electronic resource] by
- Romaguera, J E
- Rodriguez, M A
- Hagemeister, F B
- McLaughlin, P
- Swan, F
- Moore, D F
- Sarris, A H
- Younes, A
- Hill, D
- Cabanillas, F
Producer: 19950426
In:
Investigational new drugs vol. 12
Availability: No items available.
|
|
11132.
|
|
|
11133.
|
|
|
11134.
|
|
|
11135.
|
|
|
11136.
|
|
|
11137.
|
|
|
11138.
|
|
|
11139.
|
Spermine deficiency resulting from targeted disruption of the spermine synthase gene in embryonic stem cells leads to enhanced sensitivity to antiproliferative drugs. [electronic resource] by
- Korhonen, V P
- Niiranen, K
- Halmekytö, M
- Pietilä, M
- Diegelman, P
- Parkkinen, J J
- Eloranta, T
- Porter, C W
- Alhonen, L
- Jänne, J
Producer: 20010329
In:
Molecular pharmacology vol. 59
Availability: No items available.
|
|
11140.
|
|